Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes

Detalles Bibliográficos
Autores principales: Falconi, Giulia, Fabiani, Emiliano, Piciocchi, Alfonso, Criscuolo, Marianna, Fianchi, Luana, Lindfors Rossi, Elisa L., Finelli, Carlo, Cerqui, Elisa, Ottone, Tiziana, Molteni, Alfredo, Parma, Matteo, Santarone, Stella, Candoni, Anna, Sica, Simona, Leone, Giuseppe, Lo-Coco, Francesco, Voso, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462855/
https://www.ncbi.nlm.nih.gov/pubmed/30291338
http://dx.doi.org/10.1038/s41375-018-0284-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462855/
https://www.ncbi.nlm.nih.gov/pubmed/30291338
http://dx.doi.org/10.1038/s41375-018-0284-9

Ejemplares similares